INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
INO fundamentals
Inovio Pharmaceuticals (INO) released its earnings on Nov 10, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.87 (YoY +2.25%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.87
+2.25%
Report date
Nov 10, 2025
INO Earnings Call Summary for Q3,2025
- BLA Milestone Achieved: INO-3107 BLA submission completed; FDA file acceptance expected by year-end with potential mid-2026 approval.
- Cost Efficiency: 22% YoY reduction in operating expenses; cash runway extended to Q2 2026.
- Differentiated RRP Treatment: INO-3107 avoids MRD surgeries during dosing, showing 78% reduction in surgeries vs. baseline.
- Innovative Pipeline: DMAb technology achieves durable antibody production; DPROT preclinical data for Factor VIII shows promise for hemophilia.
EPS
Revenue
Revenue & Expenses
Key Indicators
Inovio Pharmaceuticals (INO) key financial stats and ratios, covering profitability, financial health, and leverage.
Inovio Pharmaceuticals (INO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Inovio Pharmaceuticals (INO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Inovio Pharmaceuticals (INO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Inovio Pharmaceuticals (INO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Inovio Pharmaceuticals (INO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Inovio Pharmaceuticals's gross profit margin?Did Inovio Pharmaceuticals beat or miss consensus estimates last quarter?What were the key takeaways from Inovio Pharmaceuticals’s earnings call?What is Inovio Pharmaceuticals's latest dividend and current dividend yield?What guidance did Inovio Pharmaceuticals's management provide for the next earnings period?What does Inovio Pharmaceuticals do and what are its main business segments?What is the market's earnings forecast for Inovio Pharmaceuticals next quarter?What is the revenue and EPS growth rate for Inovio Pharmaceuticals year over year?
